Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy
Congenital generalized lipodystrophy type 2 is a serious multisystem disorder with limited treatment options. It is caused by mutations affecting the BSCL2 gene, which encodes the protein seipin. Patients with congenital generalized lipodystrophy type 2 lack both metabolic and mechanical adipose tis...
Main Authors: | Nadine Sommer, Ahlima Roumane, Weiping Han, Mirela Delibegović, Justin J. Rochford, George D. Mcilroy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050122001395 |
Similar Items
-
<i>Bscl2</i> Deficiency Does Not Directly Impair the Innate Immune Response in a Murine Model of Generalized Lipodystrophy
by: Ahlima Roumane, et al.
Published: (2021-01-01) -
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
by: George D. Mcilroy, et al.
Published: (2020-01-01) -
Berardinelli–Seip congenital lipodystrophy 2/SEIPIN determines brown adipose tissue maintenance and thermogenic programing
by: Hongyi Zhou, et al.
Published: (2020-06-01) -
Berardinilli - Seip Congenital Generalized Lipodystrophy A Case Report
by: Riyadh Sabri Alzawbaey
Published: (2019-07-01) -
Berardinilli - Seip Congenital Generalized Lipodystrophy A Case Report
by: Riyadh Sabri Alzawbaey
Published: (2019-07-01)